Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Endogenous creatinine in serum and urine.
HARE RS. HARE RS. Proc Soc Exp Biol Med. 1950 May;74(1):148-51. doi: 10.3181/00379727-74-17837. Proc Soc Exp Biol Med. 1950. PMID: 15430417 No abstract available.
Measurement of glomerular filtration rate in the dog.
HARE RS, HARE K. HARE RS, et al. Among authors: hare k. Proc Soc Exp Biol Med. 1954 Oct;87(1):119-21. doi: 10.3181/00379727-87-21305. Proc Soc Exp Biol Med. 1954. PMID: 13224697 No abstract available.
Effect of ethyleneimine on renal action of vasopressin.
Goldblatt EL, Kauker ML, Hare RS, Hare K. Goldblatt EL, et al. Among authors: hare rs, hare k. Proc Soc Exp Biol Med. 1966 Dec;123(3):845-7. doi: 10.3181/00379727-123-31620. Proc Soc Exp Biol Med. 1966. PMID: 5959029 No abstract available.
Barnett HL, Hare K, McNamara H, Hare R. Barnett HL, et al. Among authors: hare k, hare r. J Clin Invest. 1948 Nov;27(6):691-9. doi: 10.1172/JCI102017. J Clin Invest. 1948. PMID: 16695590 Free PMC article. No abstract available.
Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.
van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. van Burik JA, et al. Among authors: hare rs. Clin Infect Dis. 2006 Apr 1;42(7):e61-5. doi: 10.1086/500212. Epub 2006 Feb 21. Clin Infect Dis. 2006. PMID: 16511748
Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5].
Bennett F, Saksena AK, Lovey RG, Liu YT, Patel NM, Pinto P, Pike R, Jao E, Girijavallabhan VM, Ganguly AK, Loebenberg D, Wang H, Cacciapuoti A, Moss E, Menzel F, Hare RS, Nomeir A. Bennett F, et al. Among authors: hare rs. Bioorg Med Chem Lett. 2006 Jan 1;16(1):186-90. doi: 10.1016/j.bmcl.2005.09.031. Epub 2005 Nov 2. Bioorg Med Chem Lett. 2006. PMID: 16260134
Activity of posaconazole in the treatment of central nervous system fungal infections.
Pitisuttithum P, Negroni R, Graybill JR, Bustamante B, Pappas P, Chapman S, Hare RS, Hardalo CJ. Pitisuttithum P, et al. Among authors: hare rs. J Antimicrob Chemother. 2005 Oct;56(4):745-55. doi: 10.1093/jac/dki288. Epub 2005 Aug 31. J Antimicrob Chemother. 2005. PMID: 16135526 Clinical Trial.
Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds.
Munayyer HK, Mann PA, Chau AS, Yarosh-Tomaine T, Greene JR, Hare RS, Heimark L, Palermo RE, Loebenberg D, McNicholas PM. Munayyer HK, et al. Among authors: hare rs. Antimicrob Agents Chemother. 2004 Oct;48(10):3690-6. doi: 10.1128/AAC.48.10.3690-3696.2004. Antimicrob Agents Chemother. 2004. PMID: 15388421 Free PMC article.
Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.
Li X, Brown N, Chau AS, López-Ribot JL, Ruesga MT, Quindos G, Mendrick CA, Hare RS, Loebenberg D, DiDomenico B, McNicholas PM. Li X, et al. Among authors: hare rs. J Antimicrob Chemother. 2004 Jan;53(1):74-80. doi: 10.1093/jac/dkh027. Epub 2003 Dec 4. J Antimicrob Chemother. 2004. PMID: 14657086
63 results
Jump to page